Sponsor pipeline

Centro Hospitalar de Lisboa Central clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 3

Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT04762992	LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)	Fetal Growth Retardation	Enrolling by Invitation	2025-08-13
Not applicable
NCT04499833	HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular…	Hepatocellular Carcinoma, Scirrhous	Recruiting	2022-06-06
Not specified
NCT07483424	Determination of Clinical Phenotypes of Intrauterine Growth Restriction in Term Infants…	Intrauterine Growth Restriction (IUGR)	Enrolling by Invitation	2026-04-02
NCT06830226	Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared…	Insufficient Breast Milk Syndrome	Enrolling by Invitation	2025-03-18

Get alerts when Centro Hospitalar de Lisboa Central's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.